What if a single vaccine platform could train the immune system to prevent multiple cancers? A new nanoparti
At the launch of Stargate Project, Oracle's Ellison said that AI could assist in identifying the cancer fragments early through a simple blood test, followed by gene sequencing of the tumour
OvarianVax, a promising cancer vaccine, is in early development as researchers identify proteins on ovarian cancer cells that trigger immune responses
Experts anticipate indigenous vaccine to help curb cases, health ministry yet to take a decision on roll-out
India's first indigenously developed quadrivalent Human Papilloma Virus (HPV) vaccine for the prevention of cervical cancer will be launched here on Thursday, officials said on Wednesday The Drugs Controller General of India (DCGI) had last month granted market authorisation to Serum Institute of India (SII) to manufacture an indigenously-developed vaccine against cervical cancer. Union Minister of Science and Technology Jitendra Singh will launch the vaccine at IIC Delhi. SII CEO Adar Poonawalla will be present at the event, the officials said. According to the officials, the qHPV vaccine CERVAVAC has demonstrated robust antibody response that is nearly 1,000 times higher than the baseline against all targeted HPV types and in all dose and age groups. Cervical cancer in India ranks as the second most frequent cancer among women between 15 and 44 years of age. The DCGI's approval had come following recommendation by the Subject Expert Committee (SEC) on COVID-19 of the CDSCO on Ju
The inclusion of this vaccine in the NIM is a significant step in reducing cervical cancer burden among women
The new treatments contain between 10 and 20 different mutated proteins, or 'neoantigens'